Bortezomib-based triplets are associated with a high probability of dialysis independence and rapid renal recovery in newly diagnosed myeloma patients with severe renal failure or those requiring dialysis-Reference-Cited by-同舟云学术

Bortezomib-based triplets are associated with a high probability of dialysis independence and rapid renal recovery in newly diagnosed myeloma patients with severe renal failure or those requiring dialysis

Published:2016-04-04 Issue:5 Volume:91 Page:499-502
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Dimopoulos Meletios A.¹,Roussou Maria¹,Gavriatopoulou Maria¹,Psimenou Erasmia¹,Eleutherakis-Papaiakovou Evangelos¹,Migkou Magdalini¹,Matsouka Charis¹,Mparmparousi Despoina¹,Gika Dimitra¹,Kafantari Eftychia¹,Ziogas Dimitrios¹,Fotiou Despoina¹,Panagiotidis Ioannis¹,Terpos Evangelos¹,Kastritis Efstathios¹

Affiliation:

1. Department of Clinical Therapeutics; National and Kapodistrian University of Athens, School of Medicine; Athens Greece

Publisher

Wiley

Subject

Hematology

Reference32 articles.

1. Renal impairment in patients with multiple myeloma: A consensus statement on behalf of the International Myeloma Working Group;Dimopoulos;J Clin Oncol,2010

2. Early mortality after diagnosis of multiple myeloma: Analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002-Medical Research Council Adult Leukaemia Working Party;Augustson;J Clin Oncol,2005

3. Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: An ERA-EDTA Registry study;Tsakiris;Nephrol Dial Transplant,2010

4. Novel approaches for reducing free light chains in patients with myeloma kidney;Hutchison;Nat Rev Nephrol,2012

5. Current treatments for renal failure due to multiple myeloma;Kastritis;Expert Opin Pharmacother,2013

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of therapeutic plasma exchange for the treatment of patients with multiple myeloma cast nephropathy;Hematological Oncology;2024-06-14

2. Kidney function in newly diagnosed myeloma patients: factors associated with kidney impairment and recovery;2024-04-16

3. Treatment outcomes of multiple myeloma in patients requiring renal replacement therapy;Journal of Renal Injury Prevention;2024-04-04

4. The role of therapeutic plasma exchange in plasma cell disorders;Annals of Hematology;2024-04-01

5. Clinicopathological characteristics and prognosis in patients with monoclonal gammopathy and renal damage in central China: a multicenter retrospective cohort study;Scientific Reports;2024-04-01